The estimated Net Worth of Robert Parks is at least $1.38 Million dollars as of 15 August 2023. Mr. Parks owns over 795 units of Syneos Health Inc stock worth over $401,605 and over the last 7 years he sold SYNH stock worth over $978,121. In addition, he makes $0 as Executive Vice President and Chief Accounting Officer at Syneos Health Inc.
Robert has made over 11 trades of the Syneos Health Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently he sold 9,113 units of SYNH stock worth $691,677 on 28 August 2023.
The largest trade he's ever made was selling 9,113 units of Syneos Health Inc stock on 28 August 2023 worth over $691,677. On average, Robert trades about 1,094 units every 80 days since 2017. As of 15 August 2023 he still owns at least 9,344 units of Syneos Health Inc stock.
You can see the complete history of Mr. Parks stock trades at the bottom of the page.
Robert Parks serves as Executive Vice President, Chief Accounting Officer of the Company. He joined the Company in November 2018 as Executive Vice President and Chief Accounting Officer and brings more than two decades of relevant experience to his new role. From May 2017 to November 2018, Mr. Parks served as Senior Vice President, Corporate Controller and principal accounting officer of IQVIA Holdings Inc. (“IQVIA”), a provider of biopharmaceutical development and commercial outsourcing services. From April 2013 to May 2017, Mr. Parks served as Vice President, Finance, of IQVIA. Prior to joining IQVIA, Mr. Parks served in leadership roles at both public and private companies, including Chief Accounting Officer at TMX Finance, LLC, a title lending business, and Head of SEC Reporting and SOX Compliance at Allscripts, Inc., a provider of technology solutions for the healthcare industry.
Robert's mailing address filed with the SEC is 3060, Olsen Drive, Santana Row, San Jose, Santa Clara County, California, 95128, United States.
Over the last 7 years, insiders at Syneos Health Inc have traded over $16,280,601,287 worth of Syneos Health Inc stock and bought 17,946 units worth $873,496 . The most active insiders traders include Todd M Abbrecht, John L. Maldonado, and Tom Allen. On average, Syneos Health Inc executives and independent directors trade stock every 14 days with the average trade being worth of $83,067,962. The most recent stock trade was executed by Michael Lee Brooks on 28 July 2022, trading 1,502 units of SYNH stock currently worth $117,156.
inc research/inventiv health has become syneos health, the only fully integrated end-to-end clinical and commercial solution organization. we are purpose-built for biopharmaceutical acceleration, creating better, smarter, faster ways to help clients navigate an increasingly complex marketplace. our new business addresses today’s market realities through clinical and commercial sharing expertise and data and insights to meet the needs of emerging and large global biopharmaceutical companies.
Syneos Health Inc executives and other stock owners filed with the SEC include: